Clinical trial
Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders…
NCT00215579 · Duke University, Other · Completed
Key facts
| NCT number | NCT00215579 |
|---|---|
| Title | Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete Adherence |
| Lead sponsor | Duke University, Other |
| Collaborators | Janssen, LP Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder |
| Intervention type | Drug |
| Interventions | Depot Risperidone Microsphere (Consta) |
| Enrollment | 64 |
| Start date | Apr 1, 2004 |
| Primary completion | Apr 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Sep 22, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: